The store will not work correctly when cookies are disabled.
(2-(2-Ethyl-3-hydroxy-4-oxopyridin-1(4H)-yl)ethoxy)-2,5-dioxopentan-1-aminium Chloride
ID: ALA4060669
PubChem CID: 137636804
Max Phase: Preclinical
Molecular Formula: C14H21ClN2O5
Molecular Weight: 296.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1c(O)c(=O)ccn1CCOC(=O)CCC(=O)CN.Cl
Standard InChI: InChI=1S/C14H20N2O5.ClH/c1-2-11-14(20)12(18)5-6-16(11)7-8-21-13(19)4-3-10(17)9-15;/h5-6,20H,2-4,7-9,15H2,1H3;1H
Standard InChI Key: OUYVYVJXWGQSHJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 21 0 0 0 0 0 0 0 0999 V2000
1.7679 -4.0955 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.5292 -3.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2437 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8148 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5292 -4.0125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1002 -3.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9582 -3.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6726 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3871 -3.1875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6726 -1.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1016 -2.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8160 -3.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5305 -2.7750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2442 -3.1909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9565 -2.7819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9607 -1.9566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2464 -1.5419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5279 -1.9526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6767 -1.5469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2414 -4.0159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5256 -4.4261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6694 -3.1972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
2 5 2 0
4 6 1 0
3 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 18 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
16 19 2 0
14 20 1 0
20 21 1 0
15 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.32 | Molecular Weight (Monoisotopic): 296.1372 | AlogP: -0.03 | #Rotatable Bonds: 8 |
Polar Surface Area: 111.62 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.54 | CX Basic pKa: 7.83 | CX LogP: 0.12 | CX LogD: -0.45 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.65 | Np Likeness Score: -0.17 |
References
1. Battah S, Hider RC, MacRobert AJ, Dobbin PS, Zhou T.. (2017) Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy., 60 (8): [PMID:28363026] [10.1021/acs.jmedchem.7b00346] |